THE ROLE OF PROCALCITONIN AS A MARKER IN CHRONIC RHEUMATIC HEART DISEASE

Read full text Summarise with VIRAT
Authors: Bobojonov Khurshid Jumaniyozovich
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic rheumatic heart disease (CRHD) remains one of the leading causes of acquired heart defects in children and adolescents in developing countries. Procalcitonin (PCT), a peptide precursor of calcitonin, is a sensitive marker of systemic inflammatory response and may reflect the activity of rheumatic inflammation and secondary bacterial infection. Determining serum procalcitonin levels may improve the early diagnosis, prognosis, and management of CRHD during exacerbations.

Fields of Study & Subjects

Streptococcal Infections and Treatments Sepsis Diagnosis and Treatment Biomarkers in Disease Mechanisms

Publication details

Journal / source
International Multidisciplinary Journal for Research & Development
Publication date
27 March 2026
Language
EN